| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromatography, High Pressure Liquid | 27 | 2018 | 315 | 5.370 |
Why?
|
| Electroosmosis | 12 | 2020 | 12 | 5.020 |
Why?
|
| Chromatography, Liquid | 22 | 2020 | 104 | 4.850 |
Why?
|
| Hippocampus | 24 | 2018 | 442 | 4.040 |
Why?
|
| Microdialysis | 10 | 2020 | 32 | 3.950 |
Why?
|
| Temperature | 16 | 2019 | 396 | 2.810 |
Why?
|
| Perfusion | 6 | 2020 | 203 | 2.550 |
Why?
|
| Cross Infection | 12 | 2015 | 141 | 2.350 |
Why?
|
| Sulfhydryl Compounds | 5 | 2020 | 69 | 2.110 |
Why?
|
| Electroporation | 10 | 2015 | 55 | 1.870 |
Why?
|
| Rats | 39 | 2020 | 3990 | 1.660 |
Why?
|
| Infection Control | 8 | 2013 | 115 | 1.590 |
Why?
|
| Rats, Sprague-Dawley | 27 | 2019 | 1219 | 1.570 |
Why?
|
| Extracellular Space | 9 | 2017 | 90 | 1.550 |
Why?
|
| Fluorescent Dyes | 8 | 2018 | 242 | 1.520 |
Why?
|
| Aminopeptidases | 3 | 2020 | 17 | 1.510 |
Why?
|
| Solvents | 13 | 2019 | 96 | 1.500 |
Why?
|
| Rotator Cuff Injuries | 2 | 2021 | 46 | 1.430 |
Why?
|
| Brain | 10 | 2020 | 2216 | 1.420 |
Why?
|
| Dopamine | 7 | 2019 | 275 | 1.410 |
Why?
|
| Polytetrafluoroethylene | 6 | 2010 | 74 | 1.410 |
Why?
|
| Enkephalin, Leucine | 3 | 2020 | 6 | 1.380 |
Why?
|
| Methicillin Resistance | 7 | 2010 | 32 | 1.300 |
Why?
|
| Vancomycin Resistance | 5 | 2010 | 18 | 1.300 |
Why?
|
| Electrochemistry | 26 | 2006 | 61 | 1.300 |
Why?
|
| Enterococcus | 5 | 2009 | 35 | 1.280 |
Why?
|
| Staphylococcal Infections | 9 | 2018 | 255 | 1.270 |
Why?
|
| Chromatography, Reverse-Phase | 2 | 2018 | 4 | 1.250 |
Why?
|
| Enzymes | 3 | 2018 | 47 | 1.240 |
Why?
|
| Silicon Dioxide | 6 | 2019 | 39 | 1.230 |
Why?
|
| Serotonin | 4 | 2013 | 218 | 1.220 |
Why?
|
| Gram-Positive Bacterial Infections | 5 | 2008 | 47 | 1.180 |
Why?
|
| Glutathione | 12 | 2017 | 104 | 1.110 |
Why?
|
| Pressure | 3 | 2016 | 165 | 1.090 |
Why?
|
| Microfluidic Analytical Techniques | 4 | 2013 | 45 | 1.080 |
Why?
|
| Thermodynamics | 6 | 2019 | 309 | 1.080 |
Why?
|
| Population Surveillance | 6 | 2018 | 219 | 1.060 |
Why?
|
| Gram-Negative Bacterial Infections | 3 | 2010 | 23 | 1.010 |
Why?
|
| Animals | 55 | 2020 | 26582 | 0.970 |
Why?
|
| Organ Culture Techniques | 9 | 2017 | 135 | 0.970 |
Why?
|
| Water | 6 | 2020 | 277 | 0.950 |
Why?
|
| Surgical Flaps | 4 | 2012 | 241 | 0.910 |
Why?
|
| Carrier State | 4 | 2018 | 39 | 0.910 |
Why?
|
| Anti-Infective Agents | 4 | 2010 | 89 | 0.890 |
Why?
|
| Cysteine | 6 | 2013 | 135 | 0.880 |
Why?
|
| Solutions | 5 | 2017 | 85 | 0.880 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 5 | 2020 | 93 | 0.860 |
Why?
|
| Electrolytes | 6 | 2012 | 52 | 0.860 |
Why?
|
| Anti-Bacterial Agents | 7 | 2012 | 746 | 0.850 |
Why?
|
| Electrodes | 11 | 2004 | 78 | 0.830 |
Why?
|
| Naphthalenes | 3 | 2010 | 45 | 0.800 |
Why?
|
| Oxygen | 5 | 2020 | 726 | 0.790 |
Why?
|
| Hydrogen-Ion Concentration | 11 | 2020 | 493 | 0.790 |
Why?
|
| Electrophoresis, Capillary | 5 | 2015 | 12 | 0.780 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 178 | 0.760 |
Why?
|
| Convection | 1 | 2020 | 12 | 0.760 |
Why?
|
| Staphylococcus aureus | 5 | 2009 | 263 | 0.760 |
Why?
|
| Lasers | 1 | 2020 | 106 | 0.750 |
Why?
|
| CA1 Region, Hippocampal | 2 | 2017 | 23 | 0.750 |
Why?
|
| Neuropeptides | 2 | 2018 | 112 | 0.740 |
Why?
|
| Click Chemistry | 1 | 2020 | 4 | 0.740 |
Why?
|
| Pyrroles | 3 | 2010 | 184 | 0.740 |
Why?
|
| Nomifensine | 2 | 2017 | 3 | 0.740 |
Why?
|
| Neuroprotective Agents | 3 | 2018 | 94 | 0.730 |
Why?
|
| Cell Membrane Permeability | 7 | 2013 | 119 | 0.730 |
Why?
|
| Hydrogels | 4 | 2018 | 82 | 0.710 |
Why?
|
| Disease Outbreaks | 4 | 2006 | 154 | 0.700 |
Why?
|
| Pharmaceutical Preparations | 2 | 2012 | 92 | 0.700 |
Why?
|
| Glucose | 5 | 2018 | 638 | 0.700 |
Why?
|
| 2,2'-Dipyridyl | 5 | 2006 | 6 | 0.690 |
Why?
|
| Conditioning, Operant | 1 | 2019 | 73 | 0.680 |
Why?
|
| Organometallic Compounds | 3 | 2006 | 132 | 0.680 |
Why?
|
| Bacterial Infections | 3 | 2009 | 182 | 0.680 |
Why?
|
| Electrophoresis | 1 | 2018 | 55 | 0.670 |
Why?
|
| Polymers | 4 | 2009 | 202 | 0.670 |
Why?
|
| Electric Stimulation | 3 | 2017 | 347 | 0.670 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2018 | 73 | 0.670 |
Why?
|
| Neurosciences | 1 | 2019 | 52 | 0.660 |
Why?
|
| Equipment Design | 8 | 2020 | 406 | 0.650 |
Why?
|
| Fungemia | 2 | 2010 | 15 | 0.650 |
Why?
|
| Shoulder Injuries | 2 | 2012 | 15 | 0.640 |
Why?
|
| Gram-Negative Bacteria | 2 | 2008 | 35 | 0.640 |
Why?
|
| Enzyme Assays | 1 | 2018 | 16 | 0.640 |
Why?
|
| Candidiasis | 2 | 2010 | 36 | 0.640 |
Why?
|
| Humans | 73 | 2021 | 86643 | 0.630 |
Why?
|
| Electrochemical Techniques | 2 | 2015 | 8 | 0.630 |
Why?
|
| Biocatalysis | 1 | 2018 | 51 | 0.630 |
Why?
|
| Patient Isolation | 2 | 2010 | 11 | 0.630 |
Why?
|
| Intensive Care Units | 4 | 2020 | 373 | 0.620 |
Why?
|
| Spectrometry, Fluorescence | 4 | 2018 | 85 | 0.610 |
Why?
|
| Coenzyme A | 2 | 2014 | 15 | 0.610 |
Why?
|
| Microelectrodes | 7 | 2008 | 81 | 0.600 |
Why?
|
| Galanin | 2 | 2015 | 6 | 0.600 |
Why?
|
| Iontophoresis | 2 | 2018 | 9 | 0.600 |
Why?
|
| Hand Hygiene | 2 | 2013 | 10 | 0.590 |
Why?
|
| Shoulder Joint | 2 | 2012 | 90 | 0.590 |
Why?
|
| Arthroscopy | 2 | 2021 | 94 | 0.590 |
Why?
|
| Brain Chemistry | 5 | 2012 | 121 | 0.590 |
Why?
|
| Indicators and Reagents | 10 | 2017 | 72 | 0.580 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2017 | 44 | 0.580 |
Why?
|
| Potassium | 2 | 2017 | 281 | 0.550 |
Why?
|
| Hydrolysis | 4 | 2020 | 141 | 0.550 |
Why?
|
| Acetonitriles | 4 | 2020 | 4 | 0.540 |
Why?
|
| Copper | 9 | 2004 | 71 | 0.540 |
Why?
|
| Insulin | 2 | 2020 | 1160 | 0.540 |
Why?
|
| Civil Defense | 1 | 2015 | 11 | 0.530 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 11 | 0.530 |
Why?
|
| Academic Medical Centers | 3 | 2015 | 379 | 0.530 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 59 | 0.530 |
Why?
|
| Male | 44 | 2020 | 40965 | 0.520 |
Why?
|
| Kinetics | 11 | 2014 | 1513 | 0.520 |
Why?
|
| Peptides | 8 | 2016 | 639 | 0.520 |
Why?
|
| Solid Phase Microextraction | 1 | 2014 | 1 | 0.510 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2014 | 15 | 0.500 |
Why?
|
| Diffusion | 6 | 2011 | 93 | 0.500 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 763 | 0.500 |
Why?
|
| Membranes, Artificial | 3 | 2005 | 40 | 0.490 |
Why?
|
| Antifungal Agents | 2 | 2016 | 117 | 0.490 |
Why?
|
| Sensitivity and Specificity | 9 | 2016 | 1991 | 0.490 |
Why?
|
| Cystamine | 1 | 2013 | 1 | 0.480 |
Why?
|
| Pantetheine | 1 | 2013 | 3 | 0.480 |
Why?
|
| Public Health | 1 | 2015 | 129 | 0.480 |
Why?
|
| Systems Integration | 1 | 2013 | 35 | 0.470 |
Why?
|
| Bacteriological Techniques | 1 | 2013 | 39 | 0.470 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2010 | 44 | 0.470 |
Why?
|
| Neostriatum | 1 | 2013 | 26 | 0.470 |
Why?
|
| Carbon | 3 | 2007 | 80 | 0.460 |
Why?
|
| Tissue Survival | 1 | 2013 | 13 | 0.460 |
Why?
|
| Cysteamine | 1 | 2013 | 1 | 0.460 |
Why?
|
| Electromagnetic Fields | 4 | 2008 | 26 | 0.460 |
Why?
|
| Particle Size | 5 | 2016 | 122 | 0.450 |
Why?
|
| Intention | 1 | 2013 | 51 | 0.450 |
Why?
|
| Fluconazole | 2 | 2010 | 10 | 0.450 |
Why?
|
| Homocysteine | 1 | 2013 | 29 | 0.450 |
Why?
|
| Chicago | 10 | 2015 | 1379 | 0.440 |
Why?
|
| Lip Neoplasms | 1 | 2012 | 8 | 0.430 |
Why?
|
| Phenobarbital | 3 | 1998 | 33 | 0.420 |
Why?
|
| Flow Injection Analysis | 2 | 2010 | 3 | 0.420 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2012 | 54 | 0.420 |
Why?
|
| Acrylates | 1 | 2011 | 19 | 0.420 |
Why?
|
| Models, Chemical | 2 | 2012 | 178 | 0.410 |
Why?
|
| Nitrosamines | 1 | 2011 | 8 | 0.410 |
Why?
|
| Electrons | 5 | 2020 | 49 | 0.410 |
Why?
|
| Aged, 80 and over | 16 | 2015 | 6509 | 0.400 |
Why?
|
| Ciprofloxacin | 3 | 2010 | 29 | 0.400 |
Why?
|
| Catheters, Indwelling | 2 | 2012 | 110 | 0.400 |
Why?
|
| Glycine | 2 | 2006 | 92 | 0.400 |
Why?
|
| Cell Physiological Phenomena | 3 | 2009 | 24 | 0.400 |
Why?
|
| Movement | 1 | 2013 | 299 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 322 | 0.400 |
Why?
|
| Carcinogens | 1 | 2011 | 108 | 0.390 |
Why?
|
| Microscopy, Fluorescence | 5 | 2011 | 425 | 0.390 |
Why?
|
| Erbium | 1 | 2010 | 1 | 0.390 |
Why?
|
| Electrophysiology | 2 | 2011 | 401 | 0.390 |
Why?
|
| Membrane Potentials | 2 | 2012 | 435 | 0.390 |
Why?
|
| Bacteria | 2 | 2017 | 447 | 0.390 |
Why?
|
| Drug Resistance, Fungal | 1 | 2010 | 8 | 0.380 |
Why?
|
| Nitrobenzenes | 2 | 2020 | 11 | 0.380 |
Why?
|
| Candida | 1 | 2010 | 17 | 0.380 |
Why?
|
| Fluorocarbons | 1 | 2010 | 72 | 0.380 |
Why?
|
| Cytological Techniques | 1 | 2010 | 30 | 0.370 |
Why?
|
| Gram-Negative Aerobic Bacteria | 1 | 2010 | 2 | 0.370 |
Why?
|
| Bacteremia | 2 | 2008 | 99 | 0.370 |
Why?
|
| Thoracic Surgery | 2 | 2008 | 43 | 0.370 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 100 | 0.370 |
Why?
|
| Cells | 1 | 2010 | 32 | 0.370 |
Why?
|
| Hospitals | 4 | 2020 | 294 | 0.370 |
Why?
|
| Dipeptides | 4 | 1995 | 46 | 0.370 |
Why?
|
| Chemical Fractionation | 1 | 2009 | 7 | 0.370 |
Why?
|
| High-Throughput Screening Assays | 1 | 2010 | 55 | 0.370 |
Why?
|
| Comet Assay | 1 | 2009 | 9 | 0.360 |
Why?
|
| Craniocerebral Trauma | 2 | 2007 | 52 | 0.360 |
Why?
|
| Mass Screening | 2 | 2013 | 618 | 0.360 |
Why?
|
| Skull Base | 2 | 2007 | 47 | 0.360 |
Why?
|
| Biosensing Techniques | 2 | 2007 | 68 | 0.360 |
Why?
|
| Animals, Newborn | 6 | 2013 | 510 | 0.350 |
Why?
|
| Chromatography, Ion Exchange | 2 | 2020 | 34 | 0.350 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 71 | 0.340 |
Why?
|
| Microtechnology | 1 | 2008 | 2 | 0.340 |
Why?
|
| Cyclodextrins | 1 | 2009 | 7 | 0.340 |
Why?
|
| Receptors, GABA-A | 2 | 2002 | 32 | 0.340 |
Why?
|
| Adult | 20 | 2021 | 25648 | 0.340 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 220 | 0.340 |
Why?
|
| Oligopeptides | 3 | 1995 | 179 | 0.340 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 62 | 0.340 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 30 | 0.330 |
Why?
|
| Astrocytes | 3 | 2017 | 139 | 0.330 |
Why?
|
| Guideline Adherence | 1 | 2010 | 223 | 0.330 |
Why?
|
| Lead | 2 | 2006 | 26 | 0.330 |
Why?
|
| Aged | 22 | 2020 | 18415 | 0.330 |
Why?
|
| Retrospective Studies | 15 | 2012 | 8489 | 0.330 |
Why?
|
| Students, Medical | 1 | 2013 | 384 | 0.330 |
Why?
|
| Age Factors | 3 | 2009 | 1851 | 0.320 |
Why?
|
| Biological Transport, Active | 1 | 2008 | 102 | 0.320 |
Why?
|
| Transfection | 2 | 2009 | 896 | 0.320 |
Why?
|
| Finite Element Analysis | 4 | 2017 | 74 | 0.320 |
Why?
|
| Melanoma | 1 | 2012 | 459 | 0.310 |
Why?
|
| Prevalence | 7 | 2018 | 1239 | 0.310 |
Why?
|
| Polyvinyl Chloride | 4 | 2012 | 8 | 0.310 |
Why?
|
| Genetic Vectors | 1 | 2009 | 439 | 0.310 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2012 | 143 | 0.300 |
Why?
|
| Skull Base Neoplasms | 1 | 2007 | 11 | 0.300 |
Why?
|
| Luminescence | 4 | 2010 | 16 | 0.300 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 546 | 0.300 |
Why?
|
| Trachea | 1 | 2008 | 293 | 0.300 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 79 | 0.290 |
Why?
|
| Models, Theoretical | 3 | 2018 | 482 | 0.290 |
Why?
|
| Catheterization, Central Venous | 1 | 2008 | 116 | 0.290 |
Why?
|
| Microsurgery | 1 | 2007 | 84 | 0.290 |
Why?
|
| Electroplating | 1 | 2006 | 2 | 0.290 |
Why?
|
| Arsenicals | 2 | 2006 | 48 | 0.290 |
Why?
|
| Female | 31 | 2020 | 44532 | 0.290 |
Why?
|
| Phosphines | 1 | 2006 | 4 | 0.280 |
Why?
|
| Palladium | 1 | 2006 | 4 | 0.280 |
Why?
|
| Microchemistry | 2 | 2004 | 6 | 0.280 |
Why?
|
| Pyramidal Cells | 2 | 2017 | 80 | 0.280 |
Why?
|
| Biogenic Monoamines | 1 | 2006 | 8 | 0.280 |
Why?
|
| Trifluoroethanol | 1 | 2006 | 2 | 0.280 |
Why?
|
| Nitrobenzoates | 1 | 2006 | 2 | 0.280 |
Why?
|
| Anthracenes | 1 | 2006 | 16 | 0.280 |
Why?
|
| Candida glabrata | 1 | 2005 | 1 | 0.280 |
Why?
|
| Fluorocarbon Polymers | 1 | 2005 | 3 | 0.280 |
Why?
|
| Microarray Analysis | 1 | 2006 | 96 | 0.280 |
Why?
|
| Photochemistry | 6 | 2006 | 38 | 0.280 |
Why?
|
| HIV Seropositivity | 1 | 2006 | 49 | 0.270 |
Why?
|
| Patient Satisfaction | 2 | 2012 | 455 | 0.270 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2018 | 74 | 0.270 |
Why?
|
| Algorithms | 2 | 2016 | 1830 | 0.270 |
Why?
|
| Surface Properties | 3 | 2016 | 130 | 0.270 |
Why?
|
| Online Systems | 2 | 2017 | 24 | 0.270 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2005 | 3 | 0.270 |
Why?
|
| Oxidation-Reduction | 6 | 2015 | 373 | 0.270 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2005 | 7 | 0.270 |
Why?
|
| Forearm | 1 | 2005 | 32 | 0.270 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2005 | 40 | 0.270 |
Why?
|
| Middle Aged | 21 | 2018 | 25028 | 0.260 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2005 | 25 | 0.260 |
Why?
|
| Head and Neck Neoplasms | 3 | 2011 | 1052 | 0.260 |
Why?
|
| Catechols | 1 | 2005 | 9 | 0.260 |
Why?
|
| Crown Ethers | 1 | 2005 | 1 | 0.260 |
Why?
|
| Cations | 2 | 2020 | 30 | 0.260 |
Why?
|
| Amino Acids | 5 | 2008 | 252 | 0.260 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 1076 | 0.260 |
Why?
|
| Risk Factors | 10 | 2020 | 5417 | 0.260 |
Why?
|
| Benzene | 2 | 2020 | 8 | 0.250 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2004 | 8 | 0.250 |
Why?
|
| Postoperative Complications | 6 | 2012 | 2207 | 0.250 |
Why?
|
| N-Methylaspartate | 3 | 2004 | 51 | 0.250 |
Why?
|
| Bioterrorism | 1 | 2004 | 18 | 0.250 |
Why?
|
| Milk, Human | 1 | 2004 | 43 | 0.250 |
Why?
|
| Barbiturates | 2 | 2002 | 12 | 0.250 |
Why?
|
| Cell Line, Tumor | 6 | 2013 | 2426 | 0.250 |
Why?
|
| Disaster Planning | 1 | 2004 | 24 | 0.250 |
Why?
|
| Corpus Striatum | 2 | 2019 | 86 | 0.250 |
Why?
|
| Diseases in Twins | 1 | 2004 | 65 | 0.250 |
Why?
|
| Spectrophotometry, Ultraviolet | 8 | 2020 | 43 | 0.240 |
Why?
|
| Rotavirus | 1 | 2004 | 11 | 0.240 |
Why?
|
| Treatment Outcome | 8 | 2021 | 7993 | 0.240 |
Why?
|
| Rotavirus Infections | 1 | 2004 | 12 | 0.240 |
Why?
|
| Cell Death | 4 | 2017 | 256 | 0.240 |
Why?
|
| Internship and Residency | 1 | 2013 | 1004 | 0.240 |
Why?
|
| Fluoroquinolones | 1 | 2003 | 22 | 0.240 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2013 | 41 | 0.240 |
Why?
|
| Epidemiological Monitoring | 2 | 2013 | 39 | 0.240 |
Why?
|
| Gastritis | 1 | 2004 | 32 | 0.240 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2003 | 13 | 0.230 |
Why?
|
| Enzyme Activation | 2 | 2018 | 692 | 0.230 |
Why?
|
| West Nile Fever | 1 | 2003 | 21 | 0.230 |
Why?
|
| Hemothorax | 1 | 2003 | 15 | 0.230 |
Why?
|
| Attitude of Health Personnel | 3 | 2013 | 636 | 0.230 |
Why?
|
| Time Factors | 8 | 2015 | 5210 | 0.230 |
Why?
|
| Trifluoroacetic Acid | 2 | 2020 | 3 | 0.230 |
Why?
|
| Otitis Media | 1 | 2003 | 18 | 0.230 |
Why?
|
| Multiple Trauma | 1 | 2003 | 34 | 0.230 |
Why?
|
| Diaphragm | 1 | 2003 | 50 | 0.230 |
Why?
|
| Single-Cell Analysis | 2 | 2015 | 134 | 0.230 |
Why?
|
| Alkenes | 1 | 2002 | 14 | 0.220 |
Why?
|
| Ethylenes | 1 | 2002 | 11 | 0.220 |
Why?
|
| Fluorine | 1 | 2002 | 17 | 0.220 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2011 | 64 | 0.220 |
Why?
|
| Case-Control Studies | 5 | 2008 | 1805 | 0.220 |
Why?
|
| Incidence | 4 | 2012 | 1577 | 0.220 |
Why?
|
| Infant, Premature | 1 | 2004 | 290 | 0.210 |
Why?
|
| Hospitals, Community | 1 | 2002 | 32 | 0.210 |
Why?
|
| Models, Biological | 3 | 2015 | 1749 | 0.210 |
Why?
|
| Anesthesia, Conduction | 1 | 2002 | 18 | 0.210 |
Why?
|
| Dicarboxylic Acids | 1 | 2002 | 22 | 0.210 |
Why?
|
| Cell Line | 6 | 2011 | 2468 | 0.210 |
Why?
|
| Bone Diseases | 1 | 2002 | 54 | 0.210 |
Why?
|
| Photosensitizing Agents | 1 | 2002 | 48 | 0.210 |
Why?
|
| Biuret | 3 | 2010 | 3 | 0.210 |
Why?
|
| Chelating Agents | 1 | 2002 | 69 | 0.210 |
Why?
|
| Nerve Block | 1 | 2002 | 51 | 0.210 |
Why?
|
| Reoperation | 3 | 2012 | 597 | 0.210 |
Why?
|
| Zinc | 1 | 2002 | 91 | 0.200 |
Why?
|
| Anesthetics, Local | 1 | 2002 | 76 | 0.200 |
Why?
|
| Kainic Acid | 2 | 2004 | 22 | 0.200 |
Why?
|
| Cells, Cultured | 7 | 2017 | 2818 | 0.200 |
Why?
|
| Urinary Bladder | 1 | 2003 | 246 | 0.200 |
Why?
|
| Aspartic Acid | 4 | 2005 | 64 | 0.200 |
Why?
|
| Adsorption | 2 | 2018 | 54 | 0.200 |
Why?
|
| Nitrogen Compounds | 1 | 2000 | 2 | 0.200 |
Why?
|
| Cell Survival | 5 | 2018 | 969 | 0.200 |
Why?
|
| Clostridium Infections | 2 | 2015 | 125 | 0.200 |
Why?
|
| Imidazoles | 1 | 2002 | 162 | 0.190 |
Why?
|
| Mitochondria | 5 | 2017 | 535 | 0.190 |
Why?
|
| Rotator Cuff | 1 | 2021 | 44 | 0.190 |
Why?
|
| Aniline Compounds | 1 | 2000 | 55 | 0.190 |
Why?
|
| Coloring Agents | 1 | 2020 | 64 | 0.190 |
Why?
|
| Propidium | 3 | 2010 | 7 | 0.190 |
Why?
|
| Quality of Health Care | 1 | 2004 | 380 | 0.190 |
Why?
|
| Elements | 1 | 2020 | 3 | 0.190 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 37 | 0.190 |
Why?
|
| Neurotransmitter Agents | 2 | 2020 | 106 | 0.180 |
Why?
|
| Poverty Areas | 1 | 2020 | 37 | 0.180 |
Why?
|
| Plasticizers | 2 | 1998 | 2 | 0.180 |
Why?
|
| Apoptosis | 3 | 2011 | 1683 | 0.180 |
Why?
|
| Neurotoxins | 1 | 1999 | 49 | 0.180 |
Why?
|
| Catheters | 1 | 2020 | 74 | 0.180 |
Why?
|
| Buffers | 3 | 2009 | 26 | 0.180 |
Why?
|
| Alkanesulfonates | 2 | 1991 | 3 | 0.180 |
Why?
|
| Confidence Intervals | 1 | 2020 | 229 | 0.180 |
Why?
|
| Electron Transport | 3 | 2010 | 71 | 0.180 |
Why?
|
| Ruthenium | 1 | 1999 | 3 | 0.180 |
Why?
|
| Rotation | 1 | 2019 | 89 | 0.180 |
Why?
|
| Neocortex | 1 | 2020 | 95 | 0.170 |
Why?
|
| Facial Paralysis | 2 | 2011 | 17 | 0.170 |
Why?
|
| Acetylene | 1 | 2019 | 3 | 0.170 |
Why?
|
| Benzene Derivatives | 1 | 2019 | 7 | 0.170 |
Why?
|
| Logistic Models | 3 | 2012 | 1186 | 0.170 |
Why?
|
| Amino Acid Sequence | 6 | 2010 | 2062 | 0.170 |
Why?
|
| Kaposi Varicelliform Eruption | 2 | 2008 | 6 | 0.170 |
Why?
|
| Chloroform | 2 | 2010 | 4 | 0.170 |
Why?
|
| Cross-Linking Reagents | 1 | 2019 | 86 | 0.170 |
Why?
|
| Sulfides | 1 | 2019 | 68 | 0.170 |
Why?
|
| Reperfusion Injury | 2 | 2017 | 131 | 0.170 |
Why?
|
| Spectrum Analysis | 1 | 2019 | 118 | 0.170 |
Why?
|
| Smallpox Vaccine | 2 | 2008 | 12 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 144 | 0.170 |
Why?
|
| Prostheses and Implants | 2 | 2011 | 121 | 0.170 |
Why?
|
| Maryland | 2 | 2009 | 35 | 0.170 |
Why?
|
| Piperacillin | 2 | 2010 | 7 | 0.160 |
Why?
|
| Disease Notification | 1 | 2018 | 3 | 0.160 |
Why?
|
| Penicillanic Acid | 2 | 2010 | 11 | 0.160 |
Why?
|
| Receptor, trkB | 1 | 2018 | 3 | 0.160 |
Why?
|
| Optical Imaging | 1 | 2018 | 48 | 0.160 |
Why?
|
| Catalysis | 2 | 2010 | 203 | 0.160 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2018 | 60 | 0.160 |
Why?
|
| Computer Simulation | 2 | 2016 | 1078 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 103 | 0.150 |
Why?
|
| Calcium | 3 | 2010 | 1156 | 0.150 |
Why?
|
| United States | 4 | 2021 | 6672 | 0.150 |
Why?
|
| Methanol | 2 | 2011 | 12 | 0.150 |
Why?
|
| Methylation | 1 | 2018 | 251 | 0.150 |
Why?
|
| Diarrhea | 2 | 2011 | 182 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 262 | 0.150 |
Why?
|
| Culture Media | 2 | 2007 | 147 | 0.150 |
Why?
|
| Itraconazole | 1 | 2016 | 11 | 0.150 |
Why?
|
| Societies, Scientific | 2 | 2007 | 44 | 0.140 |
Why?
|
| Pseudomonas Infections | 2 | 2008 | 95 | 0.140 |
Why?
|
| Advisory Committees | 2 | 2007 | 90 | 0.140 |
Why?
|
| Blood Chemical Analysis | 2 | 1989 | 42 | 0.140 |
Why?
|
| Parabens | 1 | 2016 | 4 | 0.140 |
Why?
|
| Ketones | 1 | 2016 | 13 | 0.140 |
Why?
|
| Liver Failure, Acute | 1 | 2016 | 38 | 0.140 |
Why?
|
| Wakefulness | 1 | 2017 | 134 | 0.140 |
Why?
|
| Tyrosine | 2 | 1995 | 133 | 0.140 |
Why?
|
| Receptors, Drug | 1 | 1996 | 54 | 0.140 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2016 | 69 | 0.140 |
Why?
|
| Evoked Potentials | 1 | 2017 | 190 | 0.140 |
Why?
|
| o-Phthalaldehyde | 1 | 1995 | 1 | 0.130 |
Why?
|
| Mercaptoethanol | 1 | 1995 | 8 | 0.130 |
Why?
|
| Mammals | 1 | 2017 | 227 | 0.130 |
Why?
|
| Hydrogen Peroxide | 2 | 2017 | 158 | 0.130 |
Why?
|
| Infant, Newborn | 4 | 2011 | 2379 | 0.130 |
Why?
|
| Coordination Complexes | 4 | 2006 | 19 | 0.130 |
Why?
|
| Calibration | 2 | 2013 | 99 | 0.130 |
Why?
|
| Illinois | 3 | 2018 | 462 | 0.130 |
Why?
|
| Limit of Detection | 1 | 2014 | 20 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 2262 | 0.120 |
Why?
|
| Human Activities | 1 | 2013 | 7 | 0.120 |
Why?
|
| Telemetry | 1 | 2013 | 38 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2018 | 1106 | 0.120 |
Why?
|
| Neurons | 5 | 2018 | 1546 | 0.110 |
Why?
|
| Hydrogen Bonding | 4 | 1998 | 144 | 0.110 |
Why?
|
| Societies, Medical | 2 | 2007 | 572 | 0.110 |
Why?
|
| Cytoplasm | 2 | 2015 | 281 | 0.110 |
Why?
|
| Ligands | 2 | 2006 | 433 | 0.110 |
Why?
|
| Cathartics | 1 | 2012 | 27 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2010 | 2601 | 0.110 |
Why?
|
| Urinary Diversion | 1 | 2012 | 42 | 0.110 |
Why?
|
| Pyridines | 2 | 1985 | 310 | 0.110 |
Why?
|
| Brain Ischemia | 1 | 2017 | 398 | 0.110 |
Why?
|
| Acrylamides | 1 | 2012 | 30 | 0.110 |
Why?
|
| Dextrans | 1 | 2012 | 77 | 0.110 |
Why?
|
| Child, Preschool | 5 | 2011 | 3612 | 0.110 |
Why?
|
| Porosity | 1 | 2012 | 60 | 0.100 |
Why?
|
| Solubility | 2 | 2007 | 177 | 0.100 |
Why?
|
| Certification | 1 | 2012 | 58 | 0.100 |
Why?
|
| Cystectomy | 1 | 2012 | 102 | 0.100 |
Why?
|
| Mandatory Testing | 1 | 2011 | 3 | 0.100 |
Why?
|
| Alkanesulfonic Acids | 1 | 1991 | 2 | 0.100 |
Why?
|
| Betaine | 1 | 1991 | 4 | 0.100 |
Why?
|
| Glutathione Disulfide | 3 | 2000 | 6 | 0.100 |
Why?
|
| Colony Count, Microbial | 1 | 2010 | 46 | 0.100 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 30 | 0.100 |
Why?
|
| Athletic Injuries | 1 | 2012 | 91 | 0.100 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2011 | 25 | 0.100 |
Why?
|
| Cyclization | 1 | 2010 | 10 | 0.100 |
Why?
|
| Electric Impedance | 1 | 2011 | 104 | 0.100 |
Why?
|
| Dendrimers | 1 | 2010 | 11 | 0.100 |
Why?
|
| Neuroglia | 1 | 2011 | 104 | 0.100 |
Why?
|
| Patient Admission | 1 | 2011 | 112 | 0.100 |
Why?
|
| Gold | 1 | 2011 | 41 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 102 | 0.100 |
Why?
|
| NADP | 1 | 2010 | 45 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 125 | 0.100 |
Why?
|
| Random Allocation | 1 | 2011 | 332 | 0.090 |
Why?
|
| Amides | 1 | 1990 | 60 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 160 | 0.090 |
Why?
|
| Curcumin | 1 | 2010 | 15 | 0.090 |
Why?
|
| Orthopedics | 1 | 2012 | 124 | 0.090 |
Why?
|
| Medical Staff, Hospital | 1 | 2011 | 107 | 0.090 |
Why?
|
| Microglia | 1 | 2011 | 102 | 0.090 |
Why?
|
| In Vitro Techniques | 5 | 2007 | 989 | 0.090 |
Why?
|
| Molecular Sequence Data | 5 | 1995 | 3030 | 0.090 |
Why?
|
| Organ Size | 1 | 2011 | 364 | 0.090 |
Why?
|
| Quinolones | 2 | 2010 | 60 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 363 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 894 | 0.090 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2010 | 28 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2012 | 397 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2010 | 287 | 0.090 |
Why?
|
| Klebsiella | 1 | 2009 | 6 | 0.090 |
Why?
|
| Hospitals, University | 1 | 2010 | 194 | 0.090 |
Why?
|
| Laryngoscopy | 1 | 2010 | 44 | 0.090 |
Why?
|
| Cell Culture Techniques | 2 | 2009 | 188 | 0.090 |
Why?
|
| Dexamethasone | 1 | 2011 | 326 | 0.090 |
Why?
|
| Neuroblastoma | 1 | 2013 | 374 | 0.090 |
Why?
|
| Pseudomonas | 1 | 2009 | 51 | 0.090 |
Why?
|
| gamma-Glutamyltransferase | 2 | 1999 | 16 | 0.090 |
Why?
|
| Pain | 1 | 2012 | 391 | 0.090 |
Why?
|
| Laryngeal Neoplasms | 1 | 2010 | 89 | 0.090 |
Why?
|
| Fomites | 1 | 2008 | 2 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2010 | 157 | 0.090 |
Why?
|
| Mice | 3 | 2013 | 11352 | 0.090 |
Why?
|
| Child | 4 | 2011 | 6927 | 0.090 |
Why?
|
| Vaccinia virus | 1 | 2008 | 19 | 0.080 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2008 | 13 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 508 | 0.080 |
Why?
|
| Pulmonary Atelectasis | 1 | 2008 | 18 | 0.080 |
Why?
|
| Cerebral Cortex | 3 | 2011 | 584 | 0.080 |
Why?
|
| Acinetobacter Infections | 1 | 2008 | 17 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 152 | 0.080 |
Why?
|
| Infant | 3 | 2011 | 3046 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2012 | 814 | 0.080 |
Why?
|
| Acinetobacter baumannii | 1 | 2008 | 26 | 0.080 |
Why?
|
| Rectus Abdominis | 1 | 2008 | 37 | 0.080 |
Why?
|
| Abdominal Wall | 1 | 2008 | 30 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2011 | 329 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2010 | 678 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2018 | 3241 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2705 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2013 | 2501 | 0.080 |
Why?
|
| Inflammation | 1 | 2013 | 920 | 0.080 |
Why?
|
| Equipment Contamination | 1 | 2008 | 22 | 0.080 |
Why?
|
| Gram-Positive Bacteria | 1 | 2008 | 18 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2012 | 1286 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1196 | 0.080 |
Why?
|
| Biological Transport | 2 | 2005 | 396 | 0.080 |
Why?
|
| Capillary Action | 1 | 2007 | 1 | 0.080 |
Why?
|
| Electrodes, Implanted | 1 | 2008 | 171 | 0.080 |
Why?
|
| Cell Size | 1 | 2007 | 65 | 0.080 |
Why?
|
| Methods | 1 | 2007 | 152 | 0.070 |
Why?
|
| Fluoresceins | 1 | 2007 | 43 | 0.070 |
Why?
|
| Cell Shape | 1 | 2007 | 51 | 0.070 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1986 | 79 | 0.070 |
Why?
|
| Ferrocyanides | 1 | 2006 | 3 | 0.070 |
Why?
|
| Ofloxacin | 1 | 2006 | 5 | 0.070 |
Why?
|
| Levofloxacin | 1 | 2006 | 7 | 0.070 |
Why?
|
| Automation | 1 | 2007 | 106 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 194 | 0.070 |
Why?
|
| Laryngostenosis | 1 | 2006 | 16 | 0.070 |
Why?
|
| Luminescent Measurements | 2 | 2000 | 57 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2009 | 597 | 0.070 |
Why?
|
| Tracheal Stenosis | 1 | 2006 | 23 | 0.070 |
Why?
|
| Dialysis | 1 | 2006 | 24 | 0.070 |
Why?
|
| Connexins | 1 | 2008 | 200 | 0.070 |
Why?
|
| Inpatients | 1 | 2009 | 297 | 0.070 |
Why?
|
| Econazole | 1 | 2006 | 3 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 469 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 965 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2006 | 102 | 0.070 |
Why?
|
| Volatilization | 1 | 2005 | 5 | 0.070 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2005 | 18 | 0.070 |
Why?
|
| Taurine | 3 | 2003 | 11 | 0.070 |
Why?
|
| Oxides | 1 | 2006 | 43 | 0.070 |
Why?
|
| Permeability | 1 | 2005 | 137 | 0.070 |
Why?
|
| Brain Abscess | 1 | 2005 | 8 | 0.070 |
Why?
|
| Pneumocephalus | 1 | 2005 | 10 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2008 | 839 | 0.070 |
Why?
|
| Cholesteatoma | 1 | 2005 | 7 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1578 | 0.070 |
Why?
|
| Meningitis | 1 | 2005 | 20 | 0.070 |
Why?
|
| Meningomyelocele | 1 | 2005 | 19 | 0.070 |
Why?
|
| Encephalocele | 1 | 2005 | 24 | 0.070 |
Why?
|
| Vancomycin | 1 | 2005 | 72 | 0.070 |
Why?
|
| Light | 1 | 2006 | 289 | 0.070 |
Why?
|
| Creatine | 1 | 2005 | 23 | 0.070 |
Why?
|
| Colloids | 1 | 2005 | 25 | 0.060 |
Why?
|
| Pyrazines | 1 | 2005 | 92 | 0.060 |
Why?
|
| Metalloporphyrins | 1 | 1984 | 26 | 0.060 |
Why?
|
| Protein Binding | 1 | 2009 | 1456 | 0.060 |
Why?
|
| Amines | 1 | 1984 | 27 | 0.060 |
Why?
|
| Triplets | 1 | 2004 | 8 | 0.060 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2004 | 20 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 3092 | 0.060 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 480 | 0.060 |
Why?
|
| Glycopeptides | 1 | 2004 | 16 | 0.060 |
Why?
|
| Ruthenium Compounds | 1 | 2004 | 1 | 0.060 |
Why?
|
| Colic | 1 | 2004 | 7 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 87 | 0.060 |
Why?
|
| Chemistry, Physical | 2 | 1996 | 29 | 0.060 |
Why?
|
| Chemical Phenomena | 2 | 1996 | 72 | 0.060 |
Why?
|
| Oxidative Stress | 3 | 2017 | 447 | 0.060 |
Why?
|
| Genotype | 1 | 2008 | 1851 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 2004 | 143 | 0.060 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 236 | 0.060 |
Why?
|
| Travel | 1 | 2004 | 68 | 0.060 |
Why?
|
| Headache | 1 | 2004 | 73 | 0.060 |
Why?
|
| Chiropractic | 1 | 2003 | 2 | 0.060 |
Why?
|
| Middle Ear Ventilation | 1 | 2003 | 4 | 0.060 |
Why?
|
| Lactams | 1 | 2003 | 10 | 0.060 |
Why?
|
| Pleural Effusion | 1 | 2003 | 45 | 0.060 |
Why?
|
| Miniaturization | 1 | 2003 | 13 | 0.060 |
Why?
|
| Pneumococcal Vaccines | 1 | 2003 | 28 | 0.060 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 57 | 0.060 |
Why?
|
| Ethanolamines | 2 | 2000 | 32 | 0.060 |
Why?
|
| Ascorbic Acid | 1 | 2003 | 37 | 0.060 |
Why?
|
| Fever | 1 | 2004 | 125 | 0.060 |
Why?
|
| Lacerations | 1 | 2003 | 28 | 0.060 |
Why?
|
| International Classification of Diseases | 1 | 2003 | 69 | 0.060 |
Why?
|
| Immunocompromised Host | 1 | 2004 | 140 | 0.060 |
Why?
|
| Biuret Reaction | 1 | 2002 | 1 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 938 | 0.050 |
Why?
|
| Adolescent | 3 | 2011 | 8981 | 0.050 |
Why?
|
| Isoxazoles | 2 | 1999 | 77 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2002 | 20 | 0.050 |
Why?
|
| Nausea | 1 | 2004 | 175 | 0.050 |
Why?
|
| Mesylates | 1 | 2002 | 15 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2004 | 184 | 0.050 |
Why?
|
| Recurrence | 1 | 2005 | 1139 | 0.050 |
Why?
|
| Accidents, Traffic | 1 | 2003 | 94 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 2020 | 216 | 0.050 |
Why?
|
| Acetates | 1 | 2002 | 66 | 0.050 |
Why?
|
| Morpholines | 1 | 2002 | 65 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 268 | 0.050 |
Why?
|
| Cystine | 2 | 1998 | 14 | 0.050 |
Why?
|
| Hospitalization | 1 | 2007 | 849 | 0.050 |
Why?
|
| Glutamates | 2 | 2008 | 89 | 0.050 |
Why?
|
| Acute Disease | 1 | 2003 | 826 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2015 | 305 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2002 | 321 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2002 | 272 | 0.050 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2000 | 52 | 0.050 |
Why?
|
| Dantrolene | 1 | 1999 | 5 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 2 | 2012 | 72 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 1565 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 1999 | 639 | 0.040 |
Why?
|
| Dynorphins | 1 | 1999 | 14 | 0.040 |
Why?
|
| Filtration | 1 | 1999 | 25 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 1997 | 152 | 0.040 |
Why?
|
| Ultrasonics | 1 | 1999 | 38 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 3 | 2009 | 396 | 0.040 |
Why?
|
| Reference Standards | 1 | 1999 | 159 | 0.040 |
Why?
|
| Cricetulus | 2 | 2009 | 126 | 0.040 |
Why?
|
| Drug Contamination | 1 | 1998 | 12 | 0.040 |
Why?
|
| CHO Cells | 2 | 2009 | 187 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 29 | 0.040 |
Why?
|
| Cattle | 2 | 1995 | 376 | 0.040 |
Why?
|
| DNA, Viral | 2 | 2008 | 265 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 927 | 0.040 |
Why?
|
| Propionibacterium | 1 | 2017 | 6 | 0.040 |
Why?
|
| Chlorides | 1 | 1998 | 103 | 0.040 |
Why?
|
| Staphylococcus | 1 | 2017 | 24 | 0.040 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2017 | 4 | 0.040 |
Why?
|
| Cricetinae | 2 | 2009 | 560 | 0.040 |
Why?
|
| Bicarbonates | 1 | 1997 | 60 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2008 | 293 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 1 | 2016 | 17 | 0.040 |
Why?
|
| Young Adult | 3 | 2015 | 5976 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1801 | 0.040 |
Why?
|
| Histoplasmosis | 1 | 2016 | 25 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 410 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2008 | 456 | 0.040 |
Why?
|
| PC12 Cells | 2 | 2007 | 115 | 0.040 |
Why?
|
| Glutaredoxins | 1 | 2015 | 2 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 1995 | 43 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2017 | 361 | 0.030 |
Why?
|
| Critical Illness | 1 | 2018 | 294 | 0.030 |
Why?
|
| Trypsin | 1 | 1995 | 95 | 0.030 |
Why?
|
| Cytochrome c Group | 1 | 1995 | 82 | 0.030 |
Why?
|
| Tryptophan | 1 | 1995 | 90 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2002 | 2261 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 498 | 0.030 |
Why?
|
| China | 1 | 2015 | 228 | 0.030 |
Why?
|
| Radio Frequency Identification Device | 1 | 2013 | 3 | 0.030 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2013 | 17 | 0.030 |
Why?
|
| Levamisole | 1 | 2013 | 5 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 102 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2012 | 4213 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2007 | 83 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1989 | 332 | 0.030 |
Why?
|
| Gliosis | 1 | 2011 | 35 | 0.030 |
Why?
|
| Microbiota | 1 | 2017 | 381 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2012 | 76 | 0.030 |
Why?
|
| Elastomers | 1 | 1991 | 2 | 0.030 |
Why?
|
| Butadienes | 1 | 1991 | 33 | 0.030 |
Why?
|
| Bradykinin | 1 | 1991 | 46 | 0.030 |
Why?
|
| Hydroquinones | 1 | 2011 | 8 | 0.020 |
Why?
|
| Photolysis | 1 | 1991 | 13 | 0.020 |
Why?
|
| Mathematics | 1 | 1991 | 190 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 2011 | 27 | 0.020 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2011 | 7 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 204 | 0.020 |
Why?
|
| Eyelids | 1 | 2011 | 23 | 0.020 |
Why?
|
| Keratitis | 1 | 2011 | 22 | 0.020 |
Why?
|
| 1-Naphthylamine | 1 | 2010 | 1 | 0.020 |
Why?
|
| Europium | 1 | 2010 | 2 | 0.020 |
Why?
|
| Naphthalimides | 1 | 2010 | 17 | 0.020 |
Why?
|
| Parotid Gland | 1 | 2011 | 31 | 0.020 |
Why?
|
| Focus Groups | 1 | 2011 | 155 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2012 | 141 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2011 | 104 | 0.020 |
Why?
|
| Facial Nerve | 1 | 2011 | 33 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 113 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 115 | 0.020 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2010 | 7 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1991 | 303 | 0.020 |
Why?
|
| Buthionine Sulfoximine | 1 | 2010 | 7 | 0.020 |
Why?
|
| Patient Transfer | 1 | 2011 | 91 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 273 | 0.020 |
Why?
|
| Vocal Cords | 1 | 2010 | 25 | 0.020 |
Why?
|
| Laryngectomy | 1 | 2010 | 26 | 0.020 |
Why?
|
| Hypoxia | 1 | 2015 | 641 | 0.020 |
Why?
|
| Frozen Sections | 1 | 2010 | 48 | 0.020 |
Why?
|
| Nursing Homes | 1 | 2011 | 109 | 0.020 |
Why?
|
| Feces | 1 | 2011 | 319 | 0.020 |
Why?
|
| Ischemia | 1 | 2011 | 243 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1961 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 236 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 504 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 782 | 0.020 |
Why?
|
| Catheterization | 1 | 2010 | 232 | 0.020 |
Why?
|
| Ultrafiltration | 1 | 1989 | 13 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 1989 | 45 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 912 | 0.020 |
Why?
|
| Carbidopa | 1 | 2008 | 5 | 0.020 |
Why?
|
| Kynurenic Acid | 1 | 2008 | 7 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2008 | 19 | 0.020 |
Why?
|
| Blood | 1 | 2008 | 69 | 0.020 |
Why?
|
| Cellulose | 1 | 1989 | 55 | 0.020 |
Why?
|
| Nanocapsules | 1 | 2008 | 11 | 0.020 |
Why?
|
| Isoindoles | 1 | 2008 | 14 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 2008 | 29 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1989 | 144 | 0.020 |
Why?
|
| Plasma | 1 | 2008 | 50 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 78 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 547 | 0.020 |
Why?
|
| Organophosphonates | 1 | 2008 | 50 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 712 | 0.020 |
Why?
|
| Muscles | 1 | 2008 | 194 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2011 | 319 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 154 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2008 | 293 | 0.020 |
Why?
|
| Family Health | 1 | 2008 | 162 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 66 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 316 | 0.020 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 52 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2008 | 116 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 484 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 510 | 0.020 |
Why?
|
| Cytosine | 1 | 2008 | 127 | 0.020 |
Why?
|
| Gap Junctions | 1 | 2008 | 142 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 426 | 0.020 |
Why?
|
| Benzamides | 1 | 2008 | 229 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 1204 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2008 | 172 | 0.020 |
Why?
|
| Collagen | 1 | 2008 | 269 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 212 | 0.020 |
Why?
|
| Tracheotomy | 1 | 2006 | 18 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 287 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 813 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 1163 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2007 | 193 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2007 | 420 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 1531 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 1230 | 0.020 |
Why?
|
| Pandemics | 1 | 2011 | 740 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2006 | 278 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2006 | 152 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2004 | 45 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2006 | 596 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 1939 | 0.020 |
Why?
|
| beta-Lactams | 1 | 2004 | 14 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 736 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2232 | 0.010 |
Why?
|
| Oxalates | 1 | 1983 | 48 | 0.010 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2004 | 71 | 0.010 |
Why?
|
| Micromanipulation | 1 | 2003 | 6 | 0.010 |
Why?
|
| Polymyxin B | 1 | 2003 | 4 | 0.010 |
Why?
|
| Quinacrine | 1 | 2003 | 14 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 2003 | 15 | 0.010 |
Why?
|
| Uric Acid | 1 | 1983 | 139 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2003 | 68 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2001 | 28 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2001 | 91 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 503 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2000 | 8 | 0.010 |
Why?
|
| Cell Respiration | 1 | 2000 | 18 | 0.010 |
Why?
|
| Ligation | 1 | 2000 | 51 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 2000 | 29 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2003 | 300 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2000 | 120 | 0.010 |
Why?
|
| Biophysics | 1 | 2000 | 152 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 176 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 1169 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1999 | 164 | 0.010 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 1994 | 7 | 0.010 |
Why?
|
| Ion Exchange | 1 | 1993 | 6 | 0.010 |
Why?
|
| Cholinesterases | 1 | 1990 | 17 | 0.010 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1990 | 39 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1990 | 68 | 0.010 |
Why?
|